Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer.

Breast Cancer Res · 2014 · PMC4303200 · PMID 25432519

Europe PMC DOI

hedged sentence

0.4700

closest p · 9.4× alpha

0.4700

boldest claim

The sentences

did not reach statistical significanceP = 0.47not close (p > 0.1)

Although post-treatment total CD3 counts were lower, this difference did not reach statistical significance ( P = 0.47).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.